Your browser doesn't support javascript.
loading
UK Reference Intervals for Parathyroid Hormone Using Abbott Methods.
Mirzazadeh, Mehdi; Webster, Craig; Weerasinghe, Gayani; Morris, Thomas; James, Tim; Shine, Brian.
Afiliação
  • Mirzazadeh M; Department of Chemical Pathology, Epsom and St Helier University Hospitals NHS Trust, Carshalton, United Kingdom.
  • Webster C; Department of Biochemistry, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Weerasinghe G; Department of Clinical Biochemistry, Buckinghamshire Healthcare NHS Trust, Amersham, United Kingdom.
  • Morris T; Department of Chemical Pathology, Epsom and St Helier University Hospitals NHS Trust, Carshalton, United Kingdom.
  • James T; Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Shine B; Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Br J Biomed Sci ; 80: 11224, 2023.
Article em En | MEDLINE | ID: mdl-37139470
Background: Diagnosis of hyperparathyroidism requires measurement of parathyroid hormone (PTH) in the context of the plasma calcium and other factors, such as vitamin D status and renal function. Accurate classification depends upon an appropriate population reference interval. We examined local population plasma PTH reference intervals at four different UK sites using a common platform. Methods: Plasma PTH results were extracted from laboratory information systems at four different UK sites, all using the Abbott Architect i2000 method. We included only people with normal adjusted serum calcium, magnesium, vitamin D, and renal function. Following outlier rejection lower and upper reference limits were derived. Results: An overall reference interval for plasma PTH of 3.0-13.7 pmol/L was observed using a non-parametric approach compared to 2.9-14.1 pmol/L using a parametric approach, notably higher than the manufacturer's representative range of 1.6-7.2 pmol/L. We also noted statistically significant differences (p < 0.00001) between some sites with upper limits ranging from 11.5 to 15.8 pmol/L which may be due to different population characteristics of each group. Conclusion: Locally derived reference intervals may be beneficial for UK populations and revised upper thresholds are necessary when using the Abbott PTH method to avoid inappropriate classification of patients as having hyperparathyroidism.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hormônio Paratireóideo / Hiperparatireoidismo Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hormônio Paratireóideo / Hiperparatireoidismo Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article